C

Coeptis Therapeutics Holdings
D

COEP

10.530
USD
-0.37
(-3.39%)
مغلق
حجم التداول
1,293
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
34,136,344
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Coeptis Therapeutics Holdings Inc

القطاع: Healthcare
الصناعة: Biotechnology
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.